Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Double Blind Placebo Controlled Trial of Combination Disease Modifying Antirheumatic Drugs (DMARDs) vs Monotherapy (Sulfasalazine) in Patients With Inflammatory Low Backache in Early Seronegative Spondylarthropathy

NCT01040195 is registered in ClinicalTrials.gov with Sanjay Gandhi Postgraduate Institute of Medical Sciences as lead sponsor.

NCT NCT01040195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01040195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Double Blind Placebo Controlled Trial of Combination Disease Modifying Antirheumatic Drugs (DMARDs) vs Monotherapy (Sulfasalazine) in Patients With Inflammatory Low Backache in Early Seronegative Spondylarthropathy
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2012
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seronegative spondyloarthropathies